Skip to main content

Penicillium marneffei Infection in Immunocompromised Host

Current Fungal Infection Reports volume 7, pages 44–50 (2013)Cite this article

Abstract

Penicillium marneffei (PM) was first described in 1973, causing human infection in a patient with Hodgkin Lymphoma. In the HIV/AIDS epidemic, it has been described as one of the important opportunistic infection following tuberculosis and cryptococcosis in endemic region of Southeast Asia and Southern China. Immunocompromised patients acquire penicilliosis through inhalation of conidia, resulting in disseminated disease characterized by prolonged fever, pancytopenia, hepatosplenomegaly, and classic cutaneous presentation of umbilicated papular eruption. Nowadays, rare manifestations such as fungemia, pneumonia, enterocolitis, genital ulcers, oral ulcer, and central nervous system infection have been reported. Over the past decade, molecular and genomic studies have revealed more knowledge of PM, and vaccines are under development. Modern era PM has become a serious threat in immunocompromised travelers, rather than HIV/AIDS patient in the endemic area, who receive an effective prophylaxis strategy along with the highly active antiretroviral therapy (HAART) initiation.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Chariyalertsak S, Vanittanakom P, Nelson KE, et al. Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei. J Med Vet Mycol. 1996;34:105–10.

    PubMed  Article  CAS  Google Scholar 

  2. DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol. 1973;60:259–63.

    PubMed  CAS  Google Scholar 

  3. Supparatpinyo K, Khamwan C, Baosoung V, et al. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994;344:110–3.

    Google Scholar 

  4. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis. 1996;23:125–30.

    PubMed  Article  CAS  Google Scholar 

  5. Imwidthaya P. Update of Penicillosis marneffei in Thailand. Review article. Mycopathologia. 1994;127:135–7.

    PubMed  Article  CAS  Google Scholar 

  6. Hu Y, Zhang J, Li X, Yang Y, Zhang Y Ma J, et al. Penicillium marneffei Infection: an emerging disease in Mainland China. Mycopathologia. 2012;1–11.

  7. Stern M, Romaña CA, Chovin S, Drouhet E, Danel C, Pays JF. Pulmonary Penicillium marneffei penicilliosis in a patient with acquired immunodeficiency syndrome. Presse Med. 1989;18:2067.

    Google Scholar 

  8. Carey J, Hofflich H, Amre R, et al. Penicillium marneffei infection in an immunocompromised traveler: a case report and literature review. J Trav Med. 2005;12:291–4.

    Article  Google Scholar 

  9. Nelson KSK, Vanittanakom N. Penicilliosis. In: C.A. Kauffman ea, editor. Essentials of clinical mycology: Springer Science and Business Media; 2011. p. 4419–6640.

  10. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, et al. Case–control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand. Clin Infect Dis. 1997;24:1080–6.

    PubMed  Article  CAS  Google Scholar 

  11. Hilmarsdottir I, Coutellier A, Elbaz J, et al. A French case of laboratory-acquired disseminated Penicillium marneffei infection in a patient with AIDS. Clin Infect Dis. 1994;19:357–8.

    PubMed  Article  CAS  Google Scholar 

  12. Ajello L, Padhye AA, Sukroongreung S, et al. Occurrence of Penicillium marneffei infections among wild bamboo rats in Thailand. Mycopathologia. 1995;131:1–8.

    PubMed  Article  CAS  Google Scholar 

  13. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, et al. Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir? J Infect Dis. 1996;173:1490–3.

    PubMed  Article  CAS  Google Scholar 

  14. Chaiwun B, Vanittanakom N, Jiviriyawat Y, et al. Investigation of dogs as a reservoir of Penicillium marneffei in northern Thailand. Int J Infect Dis. 2011;15:e236–9.

    PubMed  Article  Google Scholar 

  15. Kudeken N, Kawakami K, Kusano N, et al. Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J Med Vet Mycol. 1996;34:371–8.

    PubMed  Article  CAS  Google Scholar 

  16. Mootsikapun P, Srikulbutr S. Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome. Int J Infect Dis. 2006;10:66–71.

    PubMed  Article  Google Scholar 

  17. Le T, Wolbers M, Chi NH, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Vietnam. Clin Infect Dis. 2011;52:945–52.

    PubMed  Article  Google Scholar 

  18. Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect. 2002;45:268–71.

    PubMed  Article  CAS  Google Scholar 

  19. Wu TC, Chan JW, Ng CK, et al. Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004. Hong Kong Med J. 2008;14:103–9.

    PubMed  CAS  Google Scholar 

  20. Lin WC, Dai YS, Tsai MJ, et al. Systemic Penicillium marneffei infection in a child with common variable immunodeficiency. J Formos Med Assoc. 1988;97:780–3.

    Google Scholar 

  21. Luo DQ, Chen MC, Liu JH, et al. Disseminated Penicillium marneffei infection in an SLE patient: a case report and literature review. Mycopathologia. 2011;171:191–6.

    PubMed  Article  Google Scholar 

  22. Lin JN, Lin HH, Lai CH, et al. Renal transplant recipient infected with Penicillium marneffei. Lancet Infect Dis. 2010;10:138.

    PubMed  Article  Google Scholar 

  23. Lo CY, Chan DT, Yuen KY, et al. Penicillium marneffei infection in a patient with SLE. Lupus. 1995;4:229–31.

    PubMed  Article  CAS  Google Scholar 

  24. Wang JL, Hung CC, Chang SC, et al. Disseminated Penicillium marneffei infection in a renal-transplant recipient successfully treated with liposomal amphotericin B. Transplantation. 2003;76:1136–7.

    PubMed  Article  Google Scholar 

  25. Chan YH, Wong KM, Lee KC, Kwok PC, Chak WL, Choi KS, et al. Pneumonia and mesenteric lymphadenopathy caused by disseminated Penicillium marneffei infection in a cadaveric renal transplant recipient. Transpl Infect Dis. 2004;6:28–32.

    PubMed  Article  Google Scholar 

  26. Hart J, Dyer JR, Clark BM, et al. Travel-related disseminated Penicillium marneffei infection in a renal transplant patient. Transpl Infect Dis. 2012;14:434–9.

    PubMed  Article  CAS  Google Scholar 

  27. Seo JY, Ma YE, Lee JH, Lee ST, Ki CS, Lee NY. [A case of disseminated Penicillium marneffei infection in a liver transplant recipient]. Korean J Lab Med. 2010;30:400–5.

    PubMed  Article  Google Scholar 

  28. Woo PC, Lau SK, Lau CC, Chong KT, Hui WT, Wong SS, et al. Penicillium marneffei fungaemia in an allogeneic bone marrow transplant recipient. Bone Marrow Transplant. 2005;35:831–3.

    PubMed  Article  CAS  Google Scholar 

  29. Larsson M, Nguyen LH, Wertheim HF, Dao TT, Taylor W, Horby P, et al. Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam. AIDS Res Ther. 2012;9:24.

    PubMed  Article  CAS  Google Scholar 

  30. Ungpakorn R. Cutaneous manifestations of Penicillium marneffei infection. Curr Opin Infect Dis. 2000;13:129–34.

    PubMed  Article  Google Scholar 

  31. Deesomchok A, Tanprawate S. A 12-case series of Penicillium marneffei pneumonia. J Med Assoc Thai. 2006;89:441–7.

    PubMed  Google Scholar 

  32. Ma BH, Ng CS, Lam RK, Wan S, Wan IY, Lee TW, et al. Recurrent hemoptysis with Penicillium marneffei and Stenotrophomonas maltophilia in Job's syndrome. Can Respir J J Can Thorac Soc. 2009;16:e50–2.

    Google Scholar 

  33. Khongkunthian P, Isaratanan W, Samaranayake LP, Gelderblom HR, Reichart PA. Case report. Oro-facial manifestations of Penicillium marneffei infection in a Thai patient with AIDS. Mycoses. 2002;45(9–10):411–4.

    PubMed  Article  CAS  Google Scholar 

  34. Hung HG, Lok KH. Intestinal Penicillium marneffei: an unusual cause of chronic diarrhea in an AIDS patient. J Digest Dis. 2010;11:189–91.

    Article  Google Scholar 

  35. George IA, Sudarsanam TD, Pulimood AB, Mathews MS. Acute abdomen: an unusual presentation of disseminated Penicillium marneffei infection. Indian J Med Microbiol. 2008;26:180–2.

    PubMed  Article  CAS  Google Scholar 

  36. Othman N, Yip CW, Intan HI, Zainuddin Z, Amran F. An abdominal mass owing to Penicillium marneffei in an HIV-infected 7-year-old boy: case report. Ann Trop Paediatr Int Child Health. 2006;26:259–62.

    Article  CAS  Google Scholar 

  37. Cui Y, Jin C, Li X, Wu N. Penicillium marneffei infection presenting as vulva ulcer in an HIV-infected woman. Eur J Med Res. 2011;16:425–6.

    PubMed  Article  CAS  Google Scholar 

  38. Chan YF, Woo KC. Penicillium marneffei osteomyelitis. J Bone Joint Surg. 1990;72:500–3.

    CAS  Google Scholar 

  39. •• Le T, Huu Chi N, Kim Cuc NT, et al. AIDS-associated Penicillium marneffei infection of the central nervous system. Clin Infect Dis. 2010;51:1458–62. This is the first study described clinical characteristics of CNS infection of PM in AIDS patients.

    PubMed  Article  Google Scholar 

  40. Noritomi DT, Bub GL, Beer I, et al. Multiple brain abscesses due to Penicillium spp infection. Rev Inst Med Trop Sao Paulo. 2005;47:167–70.

    PubMed  Article  Google Scholar 

  41. Supparatpinyo K, Chiewchanvit S, Hirunsri P, et al. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992;14:871–4.

    Google Scholar 

  42. Woo PC, Lau SK, Liu B, et al. Draft genome sequence of Penicillium marneffei strain PM1. Eukaryot Cell. 2011;10:1740–1.

    PubMed  Article  CAS  Google Scholar 

  43. Sun J, Najafzadeh MJ, Zhang J, et al. Molecular identification of Penicillium marneffei using rolling circle amplification. Mycoses. 2011;54:e751–9.

    PubMed  Article  CAS  Google Scholar 

  44. Yuen KY, Woo PC, Lau SK. A multilocus sequence typing system for Penicillium marneffei: an international molecular cyber system for tracking its origin and transmission. Hong Kong Med J. 2010;16(5 Suppl 4):45–6.

    PubMed  CAS  Google Scholar 

  45. Pornprasert S, Praparattanapan J, Khamwan C, et al. Development of TaqMan real-time polymerase chain reaction for the detection and identification of Penicillium marneffei. Mycoses. 2009;52:487–92.

    PubMed  Article  CAS  Google Scholar 

  46. Bugeja HE, Boyce KJ, Weerasinghe H, et al. Tools for high efficiency genetic manipulation of the human pathogen Penicillium marneffei. Fungal Genet Biol. 2012;49:772–8.

    PubMed  Article  CAS  Google Scholar 

  47. Wang YF, Cai JP, Wang YD, et al. Immunoassays based on Penicillium marneffei Mp1p derived from Pichia pastoris expression system for diagnosis of penicilliosis. PLoS One. 2011;6:e28796.

    PubMed  Article  CAS  Google Scholar 

  48. Sun J, Li X, Zeng H, et al. Development and evaluation of loop- mediated isothermal amplification (LAMP) for the rapid diagnosis of Penicillium marneffei in archived tissue samples. FEMS Immunol Med Microbiol. 2010;58:381–8.

    PubMed  CAS  Google Scholar 

  49. Zhang JM, Sun JF, Feng PY, et al. Rapid identification and characterization of Penicillium marneffei using multiplex ligation-dependent probe amplification (MLPA) in paraffin-embedded tissue samples. J Microbiol Met. 2011;85:33–9.

    Article  CAS  Google Scholar 

  50. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis. 2007;7:395–401.

    Google Scholar 

  51. Gupta S, Mathur P, Maskey D, et al. Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient. AIDS Res Ther. 2007;4:21.

    PubMed  Article  Google Scholar 

  52. Saikia L, Nath R, Hazarika D, et al. Atypical cutaneous lesions of Penicillium marneffei infection as a manifestation of the immune reconstitution inflammatory syndrome after highly active antiretroviral therapy. Indian J Dermatol, Venereol Leprol. 2010;76:45–8.

    Article  Google Scholar 

  53. Sudjaritruk T, Sirisanthana T, Sirisanthana V. Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature. BMC Infect Dis. 2012;12:28.

    PubMed  Article  CAS  Google Scholar 

  54. Ho A, Shankland GS, Seaton RA. Penicillium marneffei infection presenting as an immune reconstitution inflammatory syndrome in an HIV patient. Int J STD AIDS. 2010;21:780–2.

    PubMed  Article  CAS  Google Scholar 

  55. Saikia L, Nath R, Biswanath P, et al. Penicillium marneffei infection in HIV infected patients in Nagaland & immune reconstitution after treatment. Indian J Med Res. 2009;129:333–4.

    PubMed  CAS  Google Scholar 

  56. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Infec. 2007;55:464–9.

    Article  Google Scholar 

  57. Supparatpinyo K, Nelson KE, Merz WG, et al. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother. 1993;37:2407–11.

    Google Scholar 

  58. Ryder NS. Activity of terbinafine against serious fungal pathogens. Mycoses. 1999;42 Suppl 2:115–9.

    PubMed  CAS  Google Scholar 

  59. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother. 1997;41:841–3.

    PubMed  CAS  Google Scholar 

  60. Cao C, Liu W, Li R, et al. In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei. J Antimicrob Chemother. 2009;63:340–2.

    PubMed  Article  CAS  Google Scholar 

  61. Odabasi Z, Paetznick VL, Rodriguez JR, et al. In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrob Agents Chemother. 2004;48:1912–5.

    PubMed  Article  CAS  Google Scholar 

  62. Sirisanthana T, Supparatpinyo K, Perriens J, et al. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin Infect Dis. 1998;26:1107–10.

    PubMed  Article  CAS  Google Scholar 

  63. Supparatpinyo K, Chiewchanvit S, Hirunsri P, et al. An efficacy study of itraconazole in the treatment of Penicillium marneffei infection. J Med Assoc Thai. 1992;75:688–91.

    PubMed  CAS  Google Scholar 

  64. Supparatpinyo K, Perriens J, Nelson KE, et al. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. New Engl J Med. 1998;339:1739.

    Google Scholar 

  65. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, et al. A controlled trial of Itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis. 2002;34:277–84.

    PubMed  Article  CAS  Google Scholar 

  66. Chaiwarith R, Charoenyos N, Sirisanthana T, et al. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART. AIDS. 2007;21:365–7.

    PubMed  Article  Google Scholar 

  67. • Chaiwarith R, Fakthongyoo A, Praparattanapan J, et al. Itraconazole vs fluconazole a primary prophylaxis for fungal infections in HIV-infected patients in Thailand. Currt HIV Res. 2011;9:334–8. This randomized trial demonstrated the efficacy of fluconazole compared to intraconazole.

    Article  CAS  Google Scholar 

Download references

Disclosure

M. Chitasombat: support for travel to symposia from MSD and Astella; K. Supparatpinyo: none.

Author information

Authors and Affiliations

  1. Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama 6 Road, Phyathai District, Bangkok, Thailand, 10400

    Maria Chitasombat

  2. Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

    Khuanchai Supparatpinyo

Authors
  1. Maria Chitasombat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khuanchai Supparatpinyo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Chitasombat.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chitasombat, M., Supparatpinyo, K. Penicillium marneffei Infection in Immunocompromised Host. Curr Fungal Infect Rep 7, 44–50 (2013). https://doi.org/10.1007/s12281-012-0119-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-012-0119-5

Keywords

  • Penicilliosis
  • Penicillium marneffei
  • HIV/AIDS
  • Immunocompromised